Vosaroxin
Vosaroxin is a novel first-in-class quinolone derivative that has been developed for use in the treatment of AML as a new-generation topo II inhibitor.
產(chǎn)品貨號：M1341
Back Home
版權(quán)所有格朗瑞生物科技有限公司，保留所有權(quán)利。qq:2601936984 備案:浙ICP備15036797號-1
服務(wù)熱線：
